Clinical Trial Update: Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial [NA]

View source ↗

Summary

Clinical trial update indicates the Ipilimumab-nivolumab (IPI-NIVO) combination trial for melanoma (stage III/IV) is currently recruiting at Erasmus Medical Cen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Melanoma Stage IV, Melanoma Stage III | NA | Status: RECRUITING